2014 American College of Cardiology Annual Scientific Session

2014 American College of Cardiology Annual Scientific Session | ACC 2014

ACC.14 will feature cutting-edge research and information for cardiologists, with sessions organized around 14 learning pathways covering topics in Acute Coronary Syndromes, Arrhythmias and Clinical Electrophysiology, Congenital Heart Disease, Heart Failure, and more. ACC.14 sessions will include emphasis on areas such as sports cardiology, geriatric cardiology, academic cardiology, quality, and practice management.

Conference Coverages

High Blood Pressure in Atrial Fibrillation Increases Risk of Stroke
High Blood Pressure in Atrial Fibrillation Increases Risk of Stroke
In atrial fibrillation patients, high blood pressure is associated with increased risk of stroke, according to research presented at the American College of Cardiology meeting in Washington, DC in March.
SIRS Trial: High Dose IV Steroids May Harm, Not Help Patients Who Undergo Cardiopulmonary Bypass Surgery
Treatment with methylprednisolone was associated with increased risk of myocardial infarction in high-risk patients 30 days after bypass surgery.
STAMPEDE Trial: Bariatric Surgery Beats Medical Management for Obese Patients with Diabetes
Trial data presented at ACC.14 showed bariatric surgery was associated with much better long-term glycemic control in obese patients with diabetes compared with standard intensive medical therapy alone.
GIPS-III Trial: No Benefit from Post-Myocardial Infarction Metformin in Non-Diabetic Patients
Trial results presented at ACC.14 demonstrated that treatment with metformin immediately after PCI in non-diabetic patients presenting with acute STEMI does not lead to improvements in left ventricular ejection fraction or other measure of cardiac function.
STABILITY Trial Results: Novel Plaque Inhibitor Darapladib Fails to Show Cardiovascular Benefit
Darapladib, a novel agent targeting an enzyme known to be associated with increased instability of atherosclerotic plaque, failed to show real-world benefit in a large global trial examining mortality and coronary outcomes.
Colchicine Is an Effective Treatment for Recurrent Pericarditis
Trial results showed the anti-gout medication colchicine reduced the rate of pericarditis recurrence and hospitalization compared to placebo.
CHOICE: Balloon-Expandable Sapien Valve Shows Early Edge over CoreValve Self-Expandable Device
Results from the CHOICE trial presented at ACC.14 showed the Sapien balloon-expandable valve performed slightly better than the CoreValve self-expanding device according to a composite measure of "device success."
Aleglitazar Does Not Improve Post-ACS Outcomes in Patients with Type 2 Diabetes
The AleCardio trial was halted early due to safety concerns and lack of efficacy. Investigators reported patients with diabetes and acute coronary syndrome experienced elevated risk of heart failure, gastrointestinal hemorrhage, and renal dysfunction with no mitigating cardiovascular benefit.
Biologic Agent Evolocumab Ushers in a New Era in Cholesterol-lowering Therapy
Study results presented at ACC.14 show treatment with PCSK9 inhibitor evolocumab significantly reduces LDL-cholesterol levels in patients with hypercholesterolemia.

Most Popular


$vacMongoViewPlus$ $vAR$